Literature DB >> 17573903

An evaluation of the relationship between adult height and health-related quality of life in the general UK population.

T L Christensen1, C B Djurhuus, P Clayton, J S Christiansen.   

Abstract

OBJECTIVE: Short stature has previously been shown to influence several social factors during childhood and adult life. However, limited data exist to determine the influence of short stature on health-related quality of life (HRQoL) because of underpowered studies and the fact that children find questionnaires very difficult to complete. The objective of this study was to examine the influence of height on HRQoL for the general adult population in the UK.
DESIGN: The 2003 Health Survey for England (HSE03), commissioned by the Department of Health, provides a random general population sample for the population living in private households in England. Observations for 14 416 adults (aged > 18 years) were included in the analysis. MEASUREMENTS: The survey involved a questionnaire-based interview and a nurse visit, where measurements and blood samples were taken. HRQoL was measured using the EQ-5D questionnaire. Social class (I-V) was derived according to definitions from UK National Statistics. Height was converted from centimetres to height standard deviation scores (HSDS).
RESULTS: Mean EQ-5D scores were lower in subjects with greater height deficit than in taller subjects. Three significantly different subgroups were identified using an analysis of variance (anova). The first subgroup 'HSDS </= -2.0' had significantly lower EQ-5D scores compared with the second group '-2.0 > HSDS </= 0' and the third group 'HSDS > 0'. Multivariate linear regression analysis showed significant correlations between height and HRQoL, such that an increase in height of 1 HSDS predicts an improvement in EQ-5D score of 6.1% for subjects shorter than -2.0 HSDS. Social class was a significant predictor of HRQoL in taller, but not in shorter, subjects.
CONCLUSION: The results of this study demonstrate that height in adult life is correlated with HRQoL and that short stature in adult life may be associated with a significant reduction in HRQoL.

Entities:  

Mesh:

Year:  2007        PMID: 17573903     DOI: 10.1111/j.1365-2265.2007.02901.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

1.  First-year predictors of health-related quality of life changes in short-statured children treated with human growth hormone.

Authors:  J Quitmann; J Bloemeke; H-G Dörr; M Bullinger; S Witt; N Silva
Journal:  J Endocrinol Invest       Date:  2019-03-06       Impact factor: 4.256

2.  Understanding the impact of statural height on health-related quality of life in German adolescents: a population-based analysis.

Authors:  Rachel Sommer; Anne Daubmann; Julia Quitmann; Ulrike Ravens-Sieberer; Monika Bullinger
Journal:  Eur J Pediatr       Date:  2014-12-24       Impact factor: 3.183

3.  In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.

Authors:  Cristina Barroso Hofer; Olivia Keiser; Marcel Zwahlen; Carla Sepulveda Lustosa; Ana Cristina Cisne Frota; Ricardo Hugo de Oliveira; Thalita F Abreu; Alice Weber Carvalho; Lucia Evangelista Araujo; Matthias Egger
Journal:  Pediatr Infect Dis J       Date:  2016-01       Impact factor: 2.129

Review 4.  Treatment of children and adolescents with idiopathic short stature.

Authors:  Michael B Ranke
Journal:  Nat Rev Endocrinol       Date:  2013-04-23       Impact factor: 43.330

Review 5.  Developmental influences on fertility decisions by women: an evolutionary perspective.

Authors:  D A Coall; M Tickner; L S McAllister; P Sheppard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-04-19       Impact factor: 6.237

6.  Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.

Authors:  G Schulze-Frenking; Simon A Jones; J Roberts; M Beck; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

7.  A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.

Authors:  Anya Rothenbuhler; Agnès Linglart; Pierre Bougnères
Journal:  Int J Pediatr Endocrinol       Date:  2015-02-16

8.  Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States.

Authors:  Monika Bullinger; Rachel Sommer; Andreas Pleil; Nelly Mauras; Judith Ross; Ron Newfield; Lawrence Silverman; Anja Rohenkohl; Janet Fox; Julia Quitmann
Journal:  Health Qual Life Outcomes       Date:  2015-04-02       Impact factor: 3.186

9.  Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument.

Authors:  Monika Bullinger; Julia Quitmann; Mick Power; Michael Herdman; Emmanuelle Mimoun; Kendra DeBusk; Eva Feigerlova; Carolina Lunde; Maria Dellenmark-Blom; Dolores Sanz; Anja Rohenkohl; Andreas Pleil; Hartmut Wollmann; John E Chaplin
Journal:  Health Qual Life Outcomes       Date:  2013-05-07       Impact factor: 3.186

10.  End-digits preference for self-reported height depends on language.

Authors:  Matthias Bopp; David Faeh
Journal:  BMC Public Health       Date:  2008-09-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.